Citation Impact
Citing Papers
Extracellular DNA in Pancreatic Cancer Promotes Cell Invasion and Metastasis
2013
Tough adhesives for diverse wet surfaces
2017 StandoutScience
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
2010
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
2013 Standout
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
Development of a Model for Measurement of Adhesion Strength of Fibrin Sealant to Human Tissue
1999
Extra charge and extra length of postoperative stay attributable to surgical site infection in six selected operations.
2005
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease
2001
Prospective comparison of faecal incontinence grading systems
1999 Standout
The Role of KRAS Mutation Testing in the Management of Patients With Metastatic Colorectal Cancer
2009
Cytokines in inflammatory bowel disease
2014 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Gastric Stromal Sarcoma, Pulmonary Chondroma, and Extra-adrenal Paraganglioma (Carney Triad): Natural History, Adrenocortical Component, and Possible Familial Occurrence
1999
A view on drug resistance in cancer
2019 StandoutNature
Short-term and long-term effects of caesarean section on the health of women and children
2018 Standout
A clinicopathologic and immunohistochemical study of ten pancreatic lymphangiomas and a review of the literature
1998
The Toxicology of Mercury and Its Chemical Compounds
2006 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines
2009
Lung Cancer
2008 Standout
Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study
2001
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype
2002 Standout
Crohn's disease
2012 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors
2011
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
2009 Standout
Risk Factors for Ileoanal J Pouch-Related Septic Complications in Ulcerative Colitis and Familial Adenomatous Polyposis
2002
Colorectal cancer
2013 Standout
Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections
2006
Colorectal cancer
2019 Standout
Antibody therapy of cancer
2012 Standout
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European cooperative Crohn's disease study VI
2000
Diclofenac residues as the cause of vulture population decline in Pakistan
2004 StandoutNature
Platelet Activation and Atherothrombosis
2007 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Ulcerative colitis
2012 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Crohn's disease
2016 Standout
Neutrophil extracellular traps in immunity and disease
2017 Standout
Inflammatory Bowel Disease
2002 Standout
Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the International Study Group of Rectal Cancer
2009 Standout
Preventing Postoperative Recurrence in Crohn’s Disease: What Does the Future Hold?
2013
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
2010
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
2008
Eicosanoids and cancer
2010 Standout
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
2014
Diclofenac Sodium
1988
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials
2012
ACG Clinical Guideline: Management of Benign Anorectal Disorders
2014
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial
2014
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2004
Conservative and behavioural management of constipation
2009
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease
2004
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease
2014
HIF activation identifies early lesions in VHL kidneys
2002 StandoutNobel
IOIBD technical review on endoscopic indices for Crohn's disease clinical trials
2015
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohnʼs disease
2009
Irritable Bowel Syndrome
2015 Standout
Review article: the natural history of postoperative C rohn's disease recurrence
2012
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
2008
Biology of Gastrointestinal Stromal Tumors
2004 Standout
Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples
2012
Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With EGFR Mutations
2013
Stretchable and Soft Electronics using Liquid Metals
2017 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2016
Tools and Tactics for the Optical Detection of Mercuric Ion
2008 Standout
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
2008
Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
2009
Treating Patients With EGFR-Sensitizing Mutations: First Line or Second Line—Is There a Difference?
2013
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Mercury as a Global Pollutant: Sources, Pathways, and Effects
2013 Standout
Cesarean delivery for the prevention of anal incontinence
2010
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
The role of KRAS mutation testing in the management of patients with metastatic colorectal cancer.
2009
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Works of F Michot being referenced
Experimental Measure of the Tensile Strength of Biological Sealant-Collagen Association after Hepatectomy in Dogs
1996
Temperature-controlled radio frequency energy delivery (Secca® procedure) for the treatment of fecal incontinence: results of a prospective study
2008
Alcohol-Induced Bone Marrow Damage
1987
Results of sphincteroplasty in 86 patients with anal incontinence
2000
Results of artificial sphincter in severe anal incontinence
1996
Efficacy of Sacral Nerve Stimulation for Fecal Incontinence
2005
Evaluation of selective defunctioning stoma after low anterior resection for rectal cancer
2007
Artificial Anal Sphincter in Severe Fecal Incontinence
2003
Predicting Factors of Fistula Healing and Clinical Remission After Infliximab-Based Combined Therapy for Perianal Fistulizing Crohn’s Disease
2008
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohnʼs disease
1996
Treatment of enterocele by abdominal colporectosacropexy – efficacy on pelvic pressure
2002
Prognostic Value of Circulating Mutant DNA in Unresectable Metastatic Colorectal Cancer
2010
Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy
2007
Assessment of prolonged hospital stay attributable to surgical site infections using appropriateness evaluation protocol
2000
Cytologic and molecular characterizations of CTC detected in patients with metastatic colorectal carcinomas.
2012
Assessment of prolonged hospital stay attributable to surgical site infections using appropriateness evaluation protocol
2000
[Carney's triad: a new case associated with adrenal cortex adenoma].
1990
Ileoanal anastomosis for ulcerative colitis: results of an evolutionary surgical procedure.
1999
A Double-Blind Clinical Trial to Determine if an Interaction Exists between Diclofenac Sodium and the Oral Anticoagulant Acenocoumarol (Nicoumalone)
1975
[A case of iatrogenic mercury incorporation caused by balloon rupture of a Miller-Abbot tube in intestinal subileus].
1984
[Cystic lymphangiomas of the pancreas. Three new cases].
1992